Thesis
Icon (NASDAQ:ICLR) is a leading CRO company in terms of revenues that has the potential to maintain double-digit growth rates taking advantage of industry trends. The CRO market is expected to keep growing as more and more R&D will be outsourced by pharma companies like Icon. I consider Icon as a BUY as the company is expected to continue to outperform the market growing organically and through acquisitions.
Business
Icon is a Contract Research Organization (CRO) incorporated in Ireland. As such, it provides discovery and development solutions to the pharmaceutical, biotechnology and